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Abstract: Soybeans are one of the most used alternative dietary ingredients in aquafeeds. However,
they contain phytoestrogens like genistein (GE), which can have an impact on fish metabolism and
health. This study aimed to investigate the in vitro and in vivo effects of GE on lipid metabolism,
apoptosis, and autophagy in rainbow trout (Oncorhynchus mykiss). Primary cultured preadipocytes
were incubated with GE at different concentrations, 10 or 100 µM, and 1 µM 17β-estradiol (E2).
Furthermore, juveniles received an intraperitoneal injection of GE at 5 or 50 µg/g body weight, or E2
at 5 µg/g. In vitro, GE 100 µM increased lipid accumulation and reduced cell viability, apparently
involving an autophagic process, indicated by the higher LC3-II protein levels, and higher lc3b and
cathepsin d transcript levels achieved after GE 10 µM. In vivo, GE 50 µg/g upregulated the gene
expression of fatty acid synthase (fas) and glyceraldehyde-3-phosphate dehydrogenase in adipose
tissue, suggesting enhanced lipogenesis, whereas it increased hormone-sensitive lipase in liver,
indicating a lipolytic response. Besides, autophagy-related genes increased in the tissues analyzed
mainly after GE 50 µg/g treatment. Overall, these findings suggest that an elevated GE administration
could lead to impaired adipocyte viability and lipid metabolism dysregulation in rainbow trout.
Keywords: genistein; 17β-estradiol; phytoestrogens; lipid metabolism; autophagy; apoptosis
1. Introduction
The rapid growth of aquaculture in the last years and the subsequent increase in aquafeeds
production have resulted in high demand for fishmeal and fish oil (FO). Thus, reducing their use and
developing new fish diets with alternative nutrient sources are nowadays recognized as a priority
for the future growth and sustainability of the industry [1]. In this regard, although vegetable oils
are relatively poor sources of n-3 fatty acids in comparison to FO [2], they have been incorporated as
alternative ingredients in fish diets with successful results [3–6]. Among them, soybean oil has been
one of the most used as a non-fish source of n-6 and n-3 polyunsaturated fatty acids [2,7,8].
Soy products are used in human nutrition due to their beneficial health effects. They lower the risk
factors for cardiovascular diseases by decreasing triglycerides (TAG), total cholesterol, and low-density
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lipoprotein blood levels [9]. Moreover, it has been postulated that some soy compounds might have
antioxidant [10,11] and anti-cancer properties [12,13]. Although these studies provided key information
about their valuable application in human healthcare, soy-foods have become controversial in recent
years. Of any plant, soy contains the highest concentration of isoflavones, mainly genistein (GE)
and daidzein, a class of phytoestrogens. Phytoestrogens are biologically active molecules that are
structurally similar to 17β-estradiol (E2). This resemblance enables them to bind estrogen receptors
and mimic E2 effects. However, both estrogenic and anti-estrogenic effects have been reported in
mammals depending on the model and parameter evaluated. For example, considering the effects on
adipose tissue, GE inhibited leptin secretion independently of estrogen receptor activation in murine
adipocytes, while the inhibition of adipogenesis in human adipose tissue-derived mesenchymal stem
cells by GE was estrogen receptor-dependent (reviewed in [14,15]).
These isoflavones may have positive but also negative effects in health, through impacting lipid
metabolism, which is often accompanied by alterations in the hormonal status of the organism [16].
In vitro mammalian studies have shown that GE impairs adipocyte differentiation in the 3T3-L1 cell line,
leading to apoptosis of mature adipocytes [17], and reduces lipid accumulation in a dose-dependent
manner in primary human preadipocytes, showing the cells exposed to high doses of GE a fibroblast-like
morphology instead of the characteristic round shape of mature adipocytes [18]. Regarding in vivo
assays, GE is generally considered hypolipidemic [19], but differences have been shown depending on
its content in the diet. A reduction in adipose tissue mass has also been reported in several in vivo mice
models with GE stimulating lipolysis and adipocytes apoptosis at the same time (reviewed in [14]),
while in human visceral preadipocytes, GE has been demonstrated to promote adipogenesis [20].
In addition, high levels of dietary GE included in mice diets decreased hepatic fat accumulation by
increasing fatty acid oxidation, and even a low dose of GE increased mitochondrial enzyme activity in
mice with fatty liver and obesity induced by high-fat diets, although specific effects on adipose tissue
were not mentioned in that study [21]. Moreover, it has been recently shown that GE can also influence
autophagy, the cellular degradation process by which cytoplasmic components are degraded in the
lysosomes [22]. The induction of autophagy as a result of GE exposure has been documented in human
breast MCF-7 cells [18] and several ovarian cancer cell lines [19].
The specific effect of GE and its mechanism of action on metabolically active tissues in fish
like liver or white muscle have been studied; nevertheless, the adipose tissue still remains largely
unexplored. In this sense, in vivo administration and in vitro studies have shown that GE affects
muscle protein turnover by increasing the rates of protein degradation and proteolysis-related genes
expression in rainbow trout (Oncorhynchus mykiss), via estrogen receptor-dependent and independent
mechanisms [23]. The ability of GE to produce an estrogenic effect has also been reported in Atlantic
salmon (Salmo salar) hepatocyte cells, through the increase in vitellogenin (vtg) mRNA levels [24]. Besides,
GE downregulated growth hormone/insulin-like growth factor axis-related genes and promoted changes
in several other genes’ expression, inducing a dysregulation of lipid metabolism in the liver [25]. In sea
bass (Dicentrarchus labrax) scales exposed to GE, increased enzymatic activities (alkaline phosphatase
and tartrate-resistant acid phosphatase), indicative of a higher mineral turnover, were reported, as well
as a similar response of GE and E2 in scale and liver gene expression [26]. Moreover, in the early
life stages of Senegalese sole (Solea senegalensis), GE exposure led to normal larval development and
growth, but evidence of induced apoptosis was not observed [27]. Apart from these research works,
and as far as we know, the effects of GE in fish adipose tissue have not been elucidated yet.
In this framework, the main aim of the present study was to investigate in rainbow trout the
effects of two doses of GE on lipid metabolism, apoptosis, and autophagy using in vitro and in vivo
approaches. We hypothesized, based on mammalian literature, that GE could potentially act as an
anti-adipogenic compound in rainbow trout when administered at an adequate level.
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2. Results
2.1. In Vitro Evaluation of GE Effects on Primary Cultured Adipocytes
2.1.1. Adipocyte Cells Viability, Nuclear Morphology, and LC3-II Protein Expression
Changes in nuclear morphology, as an early sign of apoptosis [28], in response to the different
treatments were observed. Generally, the nuclei from the cells under the different treatments were
rounded, while, in the case of GE 100 µM-treated cells, some of them were less circular or even showed
an elongated shape (Figure 1A). Indeed, in the quantitative analysis, the GE 100 µM treatment was
found to affect nuclear morphology, showing a reduction in nuclear area factor (NAF). However,
differences were only significant with respect to E2-exposed adipocytes, which, in turn, showed slightly
but not significantly higher NAF values than control (CT) cells (Figure 1B). In fact, GE 10 µM and
E2 did not induce significant changes in cell viability compared to CT cells; however, GE at 100 µM
significantly reduced cell viability values compared to the CT and E2 groups (Figure 1C). Concerning
the autophagy marker, microtubule-associated protein-1 light chain 3b (LC3b), significantly higher
protein expression levels of the lipidated form, LC3-II, were found in adipocytes after GE 100 µM
treatment compared to all the other conditions (Figure 2).
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mean + SEM (n = 4–6). Significant differences among treatments were determined by one-way 
ANOVA and are indicated by different letters (p < 0.05). When two groups share at least one letter, 
they are not statistically different. CT: Control; GE: Genistein; E2: 17β-estradiol. 
 
Figure 1. In vitro effects on pre-confluent rainbow trout preadipocytes incubated at day 5 of
culture for 24 h with GE at different concentrations (10 and 100 µM), E2 (1 µM), or vehicle
(0.1% DMSO) as CT. (A) Representative immunofluorescence images stained with Hoechst for nuclei
and (B) quantification of the nuclear area factor (NAF). (C) Quantification of cell viability using a
methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay. Scale bar 100 µm. Data are shown as mean
+ SEM (n = 4–6). Significant differences among treatments were determined by one-way ANOVA and
are indicated by different letters (p < 0.05). When two groups share at least one letter, they are not
statistically different. CT: Control; GE: Genistein; E2: 17β-estradiol.
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Figure 2. In vitro effects on pre-confluent rainbow trout preadipocytes incubated at day 5 of culture
for 24 h with GE at different concentrations (10 and 100 µM), E2 (1 µM), or vehicle (0.1% DMSO) as
CT. Representative Western blots and quantification of LC3-II protein levels normalized to β-tubulin.
Data are shown as mean + SEM (n = 4–6). Significant differences among treatments were determined
by one-way ANOVA and are indicated by different letters (p < 0.05). CT: Control; GE: Genistein; E2:
17β-estradiol.
2.1.2. Adipocyte Gene Expression Related to Apoptosis and Autophagy
To further characterize the in vitro effects of GE over the possible activation of apoptosis and
autophagy processes, we analyzed the gene expression of several markers from these two pathways
after a 72 h treatment. Nevertheless, only the results from GE 10 µM-treated cells are shown as the dose
of GE 100 µM caused a significant cell death to the cells and, as a result, we could not extract enough
RNA from these samples to perform the analysis. The quantitative expression of genes implicated
in apoptosis analyzed in primary cultured adipocytes did not reveal any differences among groups.
Concerning the autophagy markers, GE 10 µM significantly enhanced the mRNA levels of lc3b and
cathepsin d (ctsd) compared to CT cells, and in the case of the former, also with respect to E2-treated
cells. In addition, cathepsin l (ctsl) presented a tendency to be higher after GE exposure, although this
was not significant. Differences were not observed for autophagy-related 4b cysteine peptidase (atg4b)
and autophagy-related gene 12-like (atg12l) (Figure 3).
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comparison to the CT condition (Figure 4B). Moreover, the glycerol levels in the culture media were 
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Figure 3. In vitro effects on confluent rainbow trout preadipocytes incubated at day 7 of culture for
72 h with GE (10 µM), E2 (1 µM), or vehicle (0.1% DMSO) as CT over the expression of apoptosis- and
autophagy-related genes. Relative mRNA expression normalized to ef1α and β-actin of casp3, casp8, p53,
lc3b, atg4b, atg12l, ctsd, and ctsl. Data are shown as mean + SEM (n = 6). Significant differences among
treatments for each gene were determined by one-way ANOVA and are indicated by different letters
(p < 0.05). When two groups share at least one letter, they are not statistically different. CT: Control; GE:
Genistein; E2: 17β-estradiol.
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2.1.3. Adipocyte Differentiation, Lipid Accumulation, and Released Metabolites
The images taken after Oil Red O (ORO) staining of cultured adipocytes showed a rounder shape
and higher formation of intracellular lipid droplets in cells exposed to GE 100 µM and E2 than in CT
and GE 10 µM groups (Figure 4A), which are both characteristics of the mature adipocyte phenotype.
Quantification of specific lipid content confirmed image observation, as the exposure of rainbow trout
adipocytes to GE 100 µM and E2 significantly increased the lipid content in the cells in comparison
to the CT condition (Figure 4B). Moreover, the glycerol levels in the culture media were significantly
higher in E2-treated cells compared to the cells incubated with the two doses of GE, but not to the
CT group (Figure 4C). By contrast, released non-esterified fatty acids (NEFA) levels did not reveal
differences among groups (Figure 4D).
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Figure 4. In vitro effects on confluent rainbow trout preadipocytes incubated at day 7 of culture for
72 h with GE at different concentrations (10 and 100 µM), E2 (1 µM), or vehicle (0.1% DMSO) as CT.
(A) Representative phase-contrast images of cells after staining with ORO and (B) quantification of
lipid content. (C) Glycerol and (D) NEFA culture media levels. Scale bar 100 µm. Data are shown
as mean + SEM (n = 4–6). Significant differences among treatments were determined by one-way
ANOVA and are indicated by different letters (p < 0.05). When two groups share at least one letter, they
are not statistically different. CT: Control; GE: Genistein; E2: 17β-estradiol; ORO: Oil red O; NEFA:
Non-esterified fatty acids.
2.2. In Vivo Evaluation of GE Effects after an Intraperitoneal Injection
2.2.1. Plasma Metabolites and Hepatic Gene Expression of a Biomarker of Estrogen’s Exposure
Plasma levels of metabolites in fish administered with GE and E2 are shown in Table 1. TAG plasma
levels in GE 50 µg/g-injected fish were significan ly lo er compared to the other three groups.
In addition, the administration of E2 caused a i ifi increase in NEFA plasma concentration.
Glycerol and glucose level emained unalter upon treatments.
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Table 1. Biochemical plasma parameters of rainbow trout intraperitoneally injected with genistein (GE)
or 17β-estradiol (E2).
CT GE 5 µg/g GE 50 µg/g E2 5 µg/g
TAG (mM) 8.44 ± 1.14 a 9.12 ± 1.83 a 3.45 ± 0.81 b 11.89 ± 2.38 a
NEFA (mM) 0.151 ± 0.013 a 0.182 ± 0.012 a 0.156 ± 0.006 a 0.250 ± 0.038 b
Glucose (mM) 6.08 ± 0.46 6.37 ± 0.50 4.39 ± 0.73 5.96 ± 0.85
Plasma levels of triacyclglycerols (TAG), non-esterified fatty acids (NEFA), and glucose in rainbow trout
intraperitoneally injected with vehicle (DMSO diluted 1:3 in sesame oil) as CT, GE 5 µg/g body weight, GE
50 µg/g, or E2 5 µg/g. Data are shown as mean ± SEM (n = 4–9). Significant differences among treatments were
determined by one-way ANOVA and are indicated by different letters (a, b) (p < 0.05).
Besides, gene expression of vtg, an identified biomarker of estrogen’s exposure, was evaluated in
the liver and found significantly upregulated in the GE 50 µg/g and E2-injected fish compared to the
other two groups (Table 2).
Table 2. Gene expression of hepatic vitellogenin (vtg) in rainbow trout intraperitoneally injected with
genistein (GE) or 17β-estradiol (E2).
CT GE 5 µg/g GE 50 µg/g E2 5 µg/g
vtg 0.196 ± 0.041 a 0.168 ± 0.028 a 0.653 ± 0.100 b 1.362 ± 0.131 c
Relative mRNA expression of vtg normalized to ubq and β-actin in rainbow trout intraperitoneally injected with
vehicle (DMSO diluted 1:3 in sesame oil) as CT, GE 5 µg/g body weight, GE 50 µg/g, or E2 5 µg/g. Data are shown as
mean ± SEM (n = 6–9). Significant differences among treatments were determined by one-way ANOVA and are
indicated by different letters (a, b, c) (p < 0.05).
2.2.2. Gene Expression Related to Lipid Metabolism, Apoptosis, and Autophagy in Adipose Tissue
The de novo fatty acid synthesis of enzyme fatty acid synthase (fas) was significantly upregulated
in rainbow trout with the high dose of GE compared to the CT group. Similarly, fish administered with
GE at 50 µg/g significantly increased the gene expression of peroxisome proliferator-activated receptor
β (pparβ), glyceraldehyde-3-phosphate dehydrogenase (gapdh), and liver x receptor (lxr) with respect to
the CT animals and those treated with the low dose of GE, and in the case of lxr, also in comparison to
the E2-injected fish. Contrarily, mRNA levels of the lipoprotein lipase (lpl), the hormone-sensitive lipase
(hsl), and the transcription factor pparα did not show differences under the experimental conditions
tested (Figure 5A).
On the other hand, following GE 50 µg/g administration, caspase 3 (casp3) mRNA levels
significantly decreased compared to the CT group, while expression of lc3b and ctsd increased
in comparison to CT and E2, and atg4b compared to CT and GE 5 µg/g. The mRNA levels of ctsl were
significantly downregulated in the GE 50 µg/g and E2-injected fish compared to the other two groups.
Aside from that, changes were not found in the expression of the other apoptosis-related genes, casp8
and tumor protein p53 (p53), nor in atg12l upon treatments (Figure 5B).
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metabolism, and apoptosis- and autophagy-related genes in adipose tissue. Relative mRNA expression
normalized to ef1α and β-actin of (A) fas, lpl, hsl, pparα, pparβ, gapdh, and lxr, and (B) casp3, casp8, p53,
lc3b, atg4b, atg12l, ctsd, and ctsl. Data are shown as mean + SEM (n = 6–9). Significant differences among
treatments for each gene were determined by one-way ANOVA and are indicated by different letters
(p < 0.05). When two groups share at least one letter, they are not statistically different. CT: Control; GE:
Genistein; E2: 17β-estradiol.
2.2.3. Gene Expression Related to Lipid Metabolism, Apoptosis, and Autophagy in Liver and
White Muscle
In the liver, the transcript levels of fas were significantly downregulated but only in GE
5 µg/g-injected juveniles compared to those fish treated with the high dose of GE or E2. Concerning
lipases, lpl remained unaltered, but the lipolysis-associated gene hsl showed the highest levels of
expression in rainbow trout administered with the GE 50 µg/g dose compared to the CT group.
The mRNA levels of pparα and pparβ showed a tendency to gradually increase in a dose-dependent
manner in the animals treated with GE, although not significantly, while E2 injection significantly
upregulated pparα levels in comparison to the CT animals. Gene expression of gapdh was significantly
upregulated in the GE 50 µg/g and E2-injected fish compared to the other two groups (Figure 6A).
Transcriptional levels of casp3 in the liver were significantly higher after GE 50 µg/g and E2
injection. In addition, the gene expression of casp8 was significantly downregulated by the low dose of
GE with respect to the other three conditions, although increased in E2-injected fish in comparison
to the CT. The expression of p53 remained unaltered. Concerning the autophagic genes analyzed,
a significant decrease in lc3b was observed with E2. By contrast, the high dose of GE caused an
upregulation in the gene expression of atg4b versus the CT and the low-dose GE groups. Moreover,
atg12l and ctsd mRNA levels after E2 exposure were the highest. Gene expression of ctsl showed a
tendency to increase with GE 5 µg/g, although not significantly (Figure 6B).
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Figure 6. In vivo effects on rainbow trout intraperitoneally injected with vehicle (DMSO diluted 1:3 in
sesame oil) as CT, GE 5 µg/g, GE 50 µg/g, or E2 5 µg/g over the expression of lipid metabolism, and
apopto is- and autophagy-related genes in live . Relative mRNA expres ion normalized to ubq and
β-actin of (A) fas, lpl, hsl, pparα, pparβ, gapdh, and lxr, and (B) casp3, casp8, p53, lc3b, atg4b, atg12l, ctsd,
and ctsl. Data are shown as mean + SEM (n = 6–9). Significant differences among treatments for each
gene were determined by one-way ANOVA and are indicated by different letters (p < 0.05). When
two groups share at least one letter, they are not statistically different. CT: Control; GE: Genistein; E2:
17β-estradiol.
In white muscle, both doses of GE upregulated the mRNA levels of fas, compared to CT fish,
although only the low dose caused a significant difference with the E2 group. As observed in both
adipose tissue and liver, the gene expression levels of lpl were not affected upon treatments, while the
mRNA levels of hsl gradually increased along with the GE dose. Regarding the transcription factors,
pparα and pparβ showed significantly higher expression levels after the GE treatments compared to the
CT, except for pparβ in the GE 50 µg/g-injected fish that was not significant. pparβ mRNA levels in
E2-treated animals were also higher than those in the CT group. Moreover, the administration of GE
5 µg/g significantly decreased gapdh levels in comparison to CT and E2 groups. In addition, both doses
of GE upregulated the transcript levels of lxr compared to CT and E2-treated fish (Figure 7A).
Regarding apoptosis and autophagy, a downregulation of casp3 with respect to CT fish was
induced, in this case, after both doses of GE. On the other hand, fish exposed to E2 significantly
increased the gene expression of casp8 compared to CT and GE 5 µg/g groups, and increased p53
expression in comparison to both groups of fish treated with GE. Gene expression of atg4b and atg12l was
significantly increased in rainbow trout after GE 50 µg/g exposure and in both GE groups, respectively,
in comparison to CT and E2 groups. Finally, the administration of GE 5 µg/g significantly upregulated
ctsd with respect to the other three groups and ctsl compared to CT and E2 groups (Figure 7B).
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Figure 7. In vivo effects on rainbow trout intraperitoneally injected with vehicle (DMSO diluted 1:3 in
sesame oil) as CT, GE 5 µg/g, GE 50 µg/g, or E2 5 µg/g over the expression of lipid metabolism, and
apopto is- and autophagy-related genes in white muscle. Relative mRNA expression normalized to
ubq and ef1α of (A) fas, lpl, hsl, pp rα, pparβ, gapdh, and lxr, and (B) casp3, casp8, p53, lc3b, atg4b, tg12l,
ctsd, and ctsl. Data are shown as mean + SEM (n = 6–9). Significant differen es among treatments for
each gene were determined by one-way ANOVA a d are indicated by different letters (p < 0.05). When
two groups share at l ast one letter, th y are not statistically different. CT: Control; GE: Genistein; E2:
17β-estradiol.
2.2.4. Comparative and Qualitative Gene Expression Analysis among Tissues
Finally, to do a comparative study among tissues of the effects on gene expression, all treatments
were analyzed relative to their corresponding CT samples (Figure 8). Different expression patterns
were seen depending on the tissue and the group of genes studied. Visual interpretation of the heatmap
figures emphasizes a differential response upon GE doses in adipose tissue and liver, whereas, in white
muscle, both treatments regulated most of the genes studied in a very similar manner. Particularly, with
regard to lipid metabolism, both doses of GE upregulated (red) most of the genes analyzed in white
muscle. By contrast, in adipose tissue, only the high concentration of GE was able to induce changes in
fas, pparβ, gapdh, and lxr. Moreover, in adipose tissue, the pattern of lipid metabolism-related genes
expression induced by the high dose of GE presented a relevant degree of similarity with E2. In the
liver, contrarily to white muscle and adipose tissue, the data pointed out the downregulation (blue) of
fas in response to GE 5 µg/g while GE 50 µg/g increased hsl, as in the muscle. Moreover, the mRNA
levels of the apoptosis markers analyzed were decreased or not altered in white muscle and adipose
tissue, respectively. At the same time, in the liver, a differential response between GE doses could again
be observed. Concerning autophagy-related genes, GE induced the strongest effects in white muscle
and adipose tissue mostly at the high dose, while a weaker response was observed in the liver.
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Figure 8. Comparative heat maps showing the changes in (A) lipid metabolism and (B) apoptosis-
and autophagy-related genes expression among adipose tissue, liver, and white muscle in rainbow
trout intraperitoneally injected with GE 5 µg/g, GE 50 µg/g, or E2 5 µg/g. Gene expression was first
calculated relative to the geometric mean of the corresponding reference genes for each tissue, and then
it was standardized following a standard sc re normalization (log2) against the corresponding control
(CT) samples. Shades of red and blue, respectively, indicate the highest and lowest expression levels, as
specified in the scale bar of the figure. GE: Geni tein; E2: 17β-estradiol.
3. Discussion
Some studies have evaluated the effects of the dietary inclusion of soybean oil in replacement
of FO in several fish species, such as sea bass, rainbow trout, or Atlantic salmon, in an attempt to
decrease socioeconomic and environmental problems related to the increased pressure on arine
ingredients [29–33]. However, there is still a lack of information about how its content in phytoestrogens
(especially GE) could affect growth, metabolism, and fish health. In the current study, we evaluated the
effects of GE and E2 on rainbow trout lipid metabolism and, apoptosis and autophagy regulation, using
an in vitro culture of preadipocytes and an in vivo intraperitoneal injection as experimental models.
Cell death has been mainly associated with three different processes: Apoptosis, cell death with
autophagy, or necrosis [34], although autophagy is a complex phenomenon that can be both a cell
death mechanism but also a protective response to stressful conditions [35]. In the present study,
the lowest values of cell viability were found in GE 100 µM-treated adipocytes, together with the
lowest NAF value, which is a useful early indicator of cell morphological changes occurring during the
apoptotic process [28,36]. These effects did not seem to be induced through estrogen-like mechanisms,
as values for both parameters were significantly different from those of the E2 group. On the other
hand, preadipocytes exposed to the 100 µM dose of GE presented significantly higher protein levels of
LC3-II compared to the other three groups. LC3b is a well-known specific marker for autophagy [37],
the conserved process by which cytosolic components are trafficked to lysosomes for degradation [38].
During autophagy, LC3b is converted from a nonlipidated cytosolic form (LC3-I) to a lipidated and
phosphatidylethanol-amine-conjugated one (LC3-II) [39]. Moreover, despite the low dose of GE
did not show significant differences in the abovementioned parameters under the conditions tested,
a longer GE 10 µM treatment, upregulated at a transcriptional level lc3b, and the lysosomal enzyme
ctsd, while none of the apoptosis-related genes analyzed showed any differences in vitro. Results
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indicate that exposure to an acute high concentration of GE, or even a long treatment with a low
dose, might induce cell death potentially due to increased autophagy in rainbow trout preadipocytes.
In primary cultured human adipocytes, a very low dose of GE has been reported to increase cell
viability, whereas high concentrations of this phytoestrogen decreased it [18]. Similarly, other studies
performed in cell lines such as that of Gossner et al. [40] found a dose-dependent cytotoxic effect of GE
on human ovarian carcinoma cells A2780, CaOV3, and ES2 through both apoptosis and autophagic
mechanisms. The authors proposed that these results suggest a starvation-like signaling response,
as cells could be rescued from apoptosis with methyl pyruvate [40]. A similar response in terms of
apoptosis and cell death as a consequence of autophagy was also reported in MCF-7 breast cancer cells
when exposed to GE 100 µM [41]. Likewise, high concentrations of GE also promoted developmental
toxicity and increased mortality in zebrafish (Danio rerio) embryos [42–44]. Nevertheless, as far as we
know, studies in fish cells have not been reported to date. Overall, the present in vitro results suggest
that the cell death effect of GE in rainbow trout adipocytes could potentially be the consequence of an
excessive stimulation of autophagy and not so clearly through an apoptotic process, as reported in
mammalian models of obesity and diabetes [45], which is consistent both with the in vitro and in vivo
gene expression data of autophagic and apoptotic markers. Nevertheless, the current data represent
the first approach to understand the effects of GE on cell viability in this species, paving the way to the
study of overall autophagic flux mechanisms in the future [39]. Moreover, we have to consider from a
practical point of view that the induction of this response appears to be dose- and time-dependent;
thus, an adequate low content of phytoestrogens (i.e., GE) in fish diets could be used to avoid this
unfavorable effect.
Despite the decrease in cell viability, lipid accumulation, expressed in relation to protein,
was increased by GE 100 µM and E2 treatments in rainbow trout preadipocytes, suggesting an
adipogenic effect of GE at a high dose in this in vitro model, contrary to our initial hypothesis, which
was based on mammalian literature on preadipocyte models [17,18]. Induction of cell differentiation
in GE 100 µM and E2-treated cells also became evident by phenotypical changes, as cells acquired a
round shape in addition to being filled with lipid droplets, characteristics of mature and hypertrophic
adipocytes [46]. Adipogenesis is a multi-step process that includes the sequential activation of several
transcription factors, such as CCAAT/enhancer binding protein alpha (C/EBPα) and PPARγ [14,47].
Furthermore, adipogenesis seems to be positively regulated by some autophagic-related genes, and
indeed, the stability of PPARγ is increased by the process of autophagy in mammals [48], which is
in agreement with the elevated levels of LC3-II observed in the cells exposed to GE 100 µM in the
present work. The important role of autophagy during the whole process of adipogenesis in rainbow
trout was also previously reported by our group [49]. There, the transcriptomic analysis revealed the
coordinated expression of autophagy-related genes through the phases of proliferation and adipocyte
maturation, showing an upregulation in each case of atg5 and the lysosomal-associated membrane
protein type 2A (lamp2a), respectively. Nevertheless, to our knowledge, information is not available
about the possible pro-adipogenic and lipogenic in vitro effects of GE in fish species, nor about the
involvement of autophagy in these processes.
In primary human adipocytes, Park et al. [18] found that GE inhibited lipid accumulation in a
dose-dependent manner and, as a result of this, cells exposed to GE at a dose of 25 and 50 µM presented
a fibroblast-like morphology. Similarly, GE decreased lipid accumulation in 3T3-L1 adipocytes, even
at low concentrations of 25 µM [50]. The same anti-adipogenic effect has been reported through the
decreased expression of some of the adipocyte differentiation-related genes (e.g., cebpα, pparγ, fas, gapdh)
in the 3T3-L1 preadipocyte cell line [51] and human adipocytes [18]. Overall, these data suggested
that GE may trigger a distinct regulation of cell differentiation between fish and mammals, being
pro-adipogenic at least in rainbow trout. Nevertheless, the mechanisms underlying this differential
regulation still have to be elucidated, but specific autophagic processes associated to cell differentiation
might be involved. Notwithstanding, although most of the studies with mammalian preadipocytes
have demonstrated an opposite (i.e., anti-adipogenic) response to GE, some have shown biphasic
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effects depending on the dose, mostly using mice or human bone marrow cultures [52], while in few
cases, GE has been described as pro-adipogenic in a dose-dependent manner [53], in agreement with
the current results.
With regard to E2, Haux and Norberg [54] reported elevated levels of TAG and phospholipids in
the liver of rainbow trout after a weekly intraperitoneal injection of E2 in a 2 week trial. However,
the effect on adipose tissue was not reported. In accordance with this, elevated hepatic lipogenesis
and circulating cholesterol levels were also found in goldfish (Carassius auratus) after E2 exposure.
Again, these are effects that differ from those observed in mammals, where low E2 levels seemed to
promote lipid deposition in the liver [55]. This observation in fish agrees with the results of the present
study, where the lipid content of the cells also increased with E2 treatment, indicating a pro-adipogenic
effect. Furthermore, these data suggested that the specific GE effects on lipid accumulation described
in rainbow trout adipocytes could be mediated through E2 receptors. However, studies with specific
inhibitors would be needed to confirm this possibility.
On the other hand, in the present study, NEFA and glycerol levels released into the culture media
did not show differences between treated and CT groups. These data are consistent with the absence
of a lipolytic effect of GE, which, together with the increase in lipid accumulation as TAG caused by
this phytoestrogen and E2, already discussed, indicates that both treatments are pro-adipogenic in
rainbow trout adipocytes.
Regarding the in vivo experiment, the administration of GE and E2 via intraperitoneal injection
was selected as it offers the advantage of higher and faster exposure to the compounds than in
administration via ingestion, as injected compounds will not suffer variations in the phase of absorption
by the gastrointestinal tract, making it easier to elucidate their effects in the different tissues [56].
Adipose tissue, liver, and white muscle are described as the preferential lipid storage sites in teleost
fish [46,57], and in the present work, the expression of lipid metabolism-related genes after GE injection
revealed a differential regulation among them. Interestingly, GE at the dose of 50 µg/g and E2 elevated
the expression of vtg in liver, a reliable indicator of estrogenic activity [58]. A positive correlation
between E2 and the hepatic vtg expression is a well-established response in many fish species [58–61].
The upregulating effect of GE on vtg expression observed in this study was also reported in Atlantic
salmon hepatocyte cells [24], and in the liver of rainbow trout [25]. Furthermore, plasma VTG levels
also increased in rainbow trout after feeding a diet with a high content of phytoestrogens, including
GE and daidzein [62]. With these results, we could suggest that GE can produce an estrogenic effect by
acting as an E2-agonist in target tissues.
In adipose tissue, the mRNA levels of fas and gapdh were significantly upregulated in fish after
50 µg/g GE treatment compared to CT fish, clearly suggesting enhanced lipogenesis de novo, in line
with the in vitro results observed regarding lipid accumulation. On the other hand, the increase in pparβ
and lxr expression level may be an indication that the catabolism of fatty acids could also be activated
at a certain degree [63,64]. By contrast, in the liver, GE decreased the gene expression of fas in parallel to
upregulating hsl, indicating a lipolytic response. In white muscle, the balanced increase in lipogenesis
and lipolysis markers indicated enhanced lipid turnover in this tissue, and the coordinated upregulation
of both pparα and pparβ isoforms suggested an increased capacity for fatty acid oxidation. Contrarily
to our study, and as mentioned in the in vitro discussion, GE generally induced the opposite response
in mammalian adipose tissue. In a previous in vivo study by Naaz et al. [65], the administration of
GE, via subcutaneous injection, decreased adipose tissue weight and the size of adipocytes in mice.
Overall, in our study, the increased expression of lipogenesis markers in response to the high dose of
GE may suggest a pro-obesogenic effect, which agrees with the increased lipid accumulation observed
in cultured adipocytes, again rejecting our initial hypothesis. By contrast, our assumption applies for
liver, where a lipolytic response was found, indicating a GE anti-obesogenic effect in this tissue; in
this case, in agreement with the antisteatotic effect of GE described in humans, since hepatic TAG
contents, LDL cholesterol, and liver weight have all been demonstrated to decline dramatically after a
GE treatment [66]. In this aspect, apart from gene expression, the effects on the fish liver are not so
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well known. A previous study in liver of rainbow trout described a downregulation in pparβ, pparγ,
and rxr transcription factors and increased expression of fatty acid synthesis-related genes such as
fas in response to GE [25]. Therefore, in this species, FO replacement by soybean oil might lead to a
dysregulation in lipid metabolism, causing a possible excess of lipid deposition, lowering the quality
of the product. Nevertheless, in most cases, this response appeared to be induced only with a high
dose of GE, suggesting again that it could be attenuated by adequately controlling the amount of this
phytoestrogen incorporated in the diet.
In mammals, among its diverse properties (e.g., antioxidant, anti-inflammatory), GE has also been
shown to induce apoptosis in different models like cancer cell lines [14,40,41,67,68], in rat brain [69],
and in the adipose tissue of ovariectomized female mice [70], leading to consider this phytoestrogen as
a potential therapeutic compound for several metabolic disorders, including obesity [14]. Furthermore,
few studies have demonstrated that reduction in adipose tissue mass occurs not only as a result of
stimulating lipolysis, but also by inducing cell apoptosis [71,72]. In mammals, and in contrast to
GE, many studies have demonstrated the ability of E2 to inhibit or protect against the activation of
apoptosis in many cell types [73,74]. Moreover, although most literature in mammals has reported
the induction of apoptosis by GE, there are also references concerning the stimulation of autophagy
coming from in vitro studies [75–77]. However, information about the anti- or pro-apoptotic effects of
E2 in fish is still scarce [23,27]. In the present work, transcript levels of the apoptosis markers analyzed
were reduced or not altered by GE in adipose tissue and white muscle. On the other hand, the effect on
liver was not entirely clear, as casp3 was upregulated with the high dose of GE, but casp8 mRNA levels
were decreased with GE at 5 µg/g concentration. This agrees with the in vitro results of this study,
where the high dose of GE did not evidence a clear reduction in NAF. Similarly, Cleveland [23] found
that casp3 mRNA levels were downregulated in white muscle of rainbow trout after the administration
of GE 5 µg/g, and also casp9 with the 50 µg/g dose. Besides, daidzein, the second more important
isoflavone found in soy, diminished gene expression of both casp3 and casp9. In Senegalese sole at early
life stages, evidence of induction of apoptosis by GE was not observed at transcriptional or protein
levels, leading to normal larval development and growth [27]. Thus, unlike mammals, GE seems not
to promote apoptosis in fish species, although further cellular assays should be performed to link them
with gene expression data and confirm this hypothesis. Moreover, the effects observed in the apoptosis
markers differ in direction and magnitude between GE and E2 in all the tissues evaluated, suggesting
that, in this case, GE effects are mediated through estrogen receptor-independent mechanisms.
Concerning autophagy-related genes, the high dose of GE induced an upregulating response in
most of the genes analyzed, especially in the white muscle (lc3b, atg4b, and atg12l, although differences
were not significant for the first one) and adipose tissue (lc3b, atg4b, and ctsd). In addition, the low
dose of GE also enhanced the gene expression of ctsd and ctsl in white muscle. Moreover, the mRNA
levels of lc3b showed in the adipose tissue the same pattern as that observed at gene and protein
levels in cultured adipocytes in vitro, significantly increasing its expression with the GE 50 µg/g dose,
thus supporting the enhanced macro-autophagic condition induced by GE in rainbow trout, which
might lead to the cell death effect observed in vitro through the reduction in adipocyte viability values.
Nonetheless, the obtained results do not allow deciphering whether GE, in addition to activating
macro-autophagy, stimulates the chaperone-mediated autophagy (CMA). Until recently, the CMA
process was thought to be restricted to mammals and birds [78], and, for this reason, it was not
initially considered for the present study. However, a very recent work by Lescat and co-workers has
shown that CMA also exists in fish [79], which opens new questions for future studies. Altogether,
these data are in accordance with a previous study by Cleveland [23], which reported increased gene
expression of multiple autophagy-related genes (e.g., atg4b, lc3b, gabarapl1, ctsd) in day 7 primary
myocytes from rainbow trout exposed to a high dose of GE (100 µM). Indeed, as already mentioned,
autophagy plays an important role in adipogenesis both in mammals and fish [38,49]. This pathway
has been shown to regulate fat accumulation and PPARγ stability during adipogenesis, and to be
essential for the cytoplasmic reorganization that occurs during adipocyte differentiation [38,45,48,49].
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Moreover, studies in humans described an enhanced autophagic activity in adipose tissue from
obese or type 2 diabetic individuals, through the increase in the autophagic flux and number of
autophagosomes [80–83]. In fact, this observation agrees with the parallel lipogenic effect caused by
GE in adipose tissue, both in vitro and in vivo, and in white muscle. Aside from that, the expression
of ctsd has been demonstrated to be regulated by estrogen response elements [84] and, in a previous
study, in rainbow trout performed by Cleveland and Weber [85], ctsd increased its expression in muscle
in response to E2. In our study, this agrees with the highest gene expression of ctsd caused by E2 in
the liver, but not in the other two tissues or in response to GE. Overall, these data indicate that GE,
unlike E2, is able to modulate autophagic activity in fish, suggesting that these specific effects might be
mediated by estrogen receptor-independent mechanisms.
4. Materials and Methods
4.1. Animals and Ethics Statement
Adult (in vitro experiment) and juvenile (in vivo experiment) rainbow trout, of approximately
80 and 250 g body weight, respectively, were obtained from the fish farm Trout Factory (Peramola,
Lleida, Spain) and were acclimated for 15 days and maintained at the animal facilities (Spanish
Operational Code REGA ES080/90036535) of the Faculty of Biology at the University of Barcelona
(Spain). Animals were kept either in 0.2 or 0.4 m3 tanks under a 12 h light/12 h dark photoperiod with
a temperature-controlled freshwater recirculation system at 18 ± 1 ◦C, and fed ad libitum twice daily
with a commercial diet (Optiline-sf, Skretting, Burgos, Spain). Prior to sampling, juveniles were fasted
from 2 h before the injection to 24 h post-injection (26 h), and adults for 24 h to avoid contamination
from the gastrointestinal tract in the adipose tissue samples. Fish were anesthetized with MS-222
(0.1 g/l) (E10521, Sigma-Aldrich, Tres-Cantos, Spain) according to its effective dose in this species
and sacrificed by a blow to the head before tissues sampling [86]. All animal handling procedures
complied with the Ethics and Animal Care Committee of the University of Barcelona, in accordance
with the guidelines of the European Union Council directive (2010/63 EU), and the Spanish and Catalan
Government assigned principles and legislation (permit numbers CEEA OB35/17 and CEEA 311/15 for
the in vitro and in vivo experiments, respectively).
4.2. Primary Culture of Preadipocytes and Experimental Treatments
Primary cultures of rainbow trout preadipocytes were performed as previously described in
Bouraoui et al. [87]. Briefly, after mechanical and enzymatic digestion of the tissue, the cells obtained
were washed and counted. Then, cells were seeded at a final density of 2–2.5 × 104 cells/cm2 in 1%
gelatin-pretreated six-well plates (9.6 cm2/well) for Western blot and gene expression or twelve-well
plates (2.55 cm2/well), with or without glass coverslips accordingly, for the viability assay, nuclear
morphology analysis, ORO staining, and culture media parameters determination. Cells were cultured
in Leibovitz’s L-15 medium (11415, Life Technologies, Alcobendas, Spain) supplemented with 10%
fetal bovine serum and 1% of antibiotic-antimycotic solution (A5955, Sigma-Aldrich, Tres-Cantos,
Spain) (growth medium, GM). The medium was changed every 2 days. Once confluence was reached
(day 7), cells were induced to differentiate by means of incubation with a differentiation medium
(DM) based on GM supplemented with 10 µg/mL insulin (I6634, Sigma-Aldrich, Tres-Cantos, Spain),
0.5 mM 3-isobutyl-1-methylxanthine (IBMX) (I5879, Sigma-Aldrich, Tres-Cantos, Spain), 0.25 µM
dexamethasone (D4902, Sigma-Aldrich, Tres-Cantos, Spain), and 5 µl/mL lipid mixture (4.5 mg/mL
cholesterol, 10 mg/mL cod liver oil, 25 mg/mL polyoxyethylenesorbitan monooleate, and 2 mg/mL
D-α-tocopherolacetate) (L5146, Sigma-Aldrich, Tres Cantos, Spain). All plastic materials were obtained
from Nunc (LabClinics, Barcelona, Spain).
GE (G6649, Sigma-Aldrich, Tres-Cantos, Spain) and E2 (E2758, Sigma-Aldrich, Tres-Cantos, Spain),
used as a positive CT of the estrogenic effect, were applied at day 5 for 24 h to determine cell viability,
nuclear morphology, and perform Western blots, or at day 7 for 72 h to measure biochemical parameters
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in culture media, lipid accumulation, and gene expression. GE and E2 were dissolved in dimethyl
sulfoxide (DMSO), but the final concentration of DMSO added to the cells was 0.1% in all cases, which
do not compromise cell integrity [28]. The treatments were the following: 1) CT (DMSO as vehicle),
2) GE 10 µM, 3) GE 100 µM, and 4) E2 1 µM. Doses were selected according to previous in vitro
studies [18,23,41]. Four independent cultures were performed to perform Western blot (n = 4); six to
assess cell viability, nuclear morphology, gene expression and biochemical parameters in culture media
(n = 6); and twelve to analyze lipid accumulation (n = 12).
4.3. Cell Viability Assay
The methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay was used to evaluate cell viability.
Briefly, pre-confluent adipocyte samples of two duplicate wells of the 12-well plates were incubated
the last 18 h of the total 24 h treatment with a final concentration of 0.5 mg/mL of MTT (M5655,
Sigma-Aldrich, Tres-Cantos, Spain). Next, cells were washed with PBS and the blue formazan
crystals were allowed to resuspend in DMSO for 3 h. The viability values were obtained from the
absorbance measured at 570 nm in duplicate 96-wells, with correction at 650 nm, using a microplate
reader (Tecan Infinite M200, Männedorf, Switzerland). The value from cells containing PBS instead
of MTT was also subtracted. Data are presented as a fold change relative to the CT group (n = 6
independent cultures).
4.4. Nuclear Morphology Analysis
NAF was used as a cell shape descriptor to assess apoptosis, as previously described [88].
After treatments incubation, cells attached to coverslips were fixed for 15 min with 4% paraformaldehyde
in PBS containing 60 mM sucrose. After washing twice with PBS, and twice with PBS containing 20 mM
glycine (PBS-glycine), permeabilization of cell membranes was done during 10 min with PBS-glycine
supplemented with 0.05% saponin, and cell samples were subsequently rinsed with PBS. At this point,
coverslips were blocked for 20 min with PBS-glycine containing 1% of BSA and then incubated for
15 min with 1% BSA and 0.025% saponin in PBS-glycine plus the DNA-specific fluorescent dye Hoechst
33342 (1 µg/mL) to stain the cell nuclei. Confocal images were obtained using a Leica TCS SP2 confocal
microscope (Leica Microsystems, Mannheim, Germany) and processed with ImageJ software (National
Institutes of Health, Bethesda, MD, USA). Per condition, ten random fields per coverslip were recorded
and, per each culture, duplicate coverslips from 12-well plates were analyzed. NAF values were
obtained from the product of nuclear area and roundness. All images were analyzed by the same
researcher in a blinded manner (n = 4–6 independent cultures).
4.5. Western Blot
The protein levels of the lipidated form of LC3 (LC3-II), a biomarker of autophagy, were analyzed
by Western blot, following a previously published protocol [89], with slight modifications. Briefly,
protein was extracted from cell samples of two duplicate wells from the 6-well plates with RIPA buffer
(supplemented with proteases and phosphatases inhibitors). Samples were cooled on ice for 20 min and
the supernatants were collected after a centrifuge at 12,000 rpm for 10 min. Then, quantification was
done by the Bradford method and 2.7 µg of protein from each sample was subjected to sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) on 20% polyacrylamide gels containing 6 M
urea (100 V for 2 h) and transferred to PVDF-FL membranes in transfer buffer (100 V and 75 min).
At this point, membranes were blocked at RT for 1 h with an Odyssey® Blocking buffer in TBS (Cat. No.
927-50000, Servicios Hospitalarios, Barcelona, Spain), and incubated overnight at 4 ◦C with rabbit
polyclonal anti-LC3b antibody (1:300, Cat. No. 2775) and rabbit polyclonal anti-β-Tubulin (1:1000,
Cat. No 2146), all from Cell Signaling Technology (Beverly, MA, USA), in the same blocking buffer.
After washing 3 times with PBS-Tween 0.05%, membranes were incubated with a goat anti-rabbit
fluorescence-conjugated secondary antibody (1:5000, Cat. No. 925-32211, Servicios Hospitalarios,
Barcelona, Spain) for 1 h. Next, membranes were rewashed again, 3 times with PBS-Tween and twice
Int. J. Mol. Sci. 2020, 21, 5884 16 of 24
with PBS, and the band signals were detected at 600 and 700 nm with the Odyssey® FC Imaging System
(LI-COR Inc. Biotechnology, Lincoln, NE, USA). Finally, the bands were quantified by Odyssey®
software Image Studio ver. 5.2.5. Data of LC3-II protein expression are presented as a fold change
relative to each corresponding β-Tubulin protein expression (n = 4 independent cultures).
4.6. Oil Red O Staining
Intracellular neutral lipid accumulation was analyzed by ORO staining, performed as in previous
studies [28,90]. After 72 h treatments, cells were fixed for 1 h with 10% formalin and stained with
0.3% ORO (O0625, Sigma-Aldrich, Tres-Cantos, Spain) diluted in 36% triethyl phosphate during
2 h. After washing the excessive dye with distilled water and resuspending it in isopropanol,
the quantification of the lipid content was calculated as the quotient of the absorbance measured at
490 nm by the one at 630 nm in duplicate 96-wells, using a microplate reader (Tecan Infinite M200,
Männedorf, Switzerland). The reading at 630 nm corresponds to cell protein content, which was
acquired by using the Coomassie brilliant blue G-250 dye for 1 h after finishing the ORO procedure,
and extraction of the stain with propylene glycol during 1 h at 60 ◦C. Data are presented as the ratio of
absorbance value between ORO and Coomassie blue staining (n = 12 independent cultures). The ORO
staining effectiveness was assessed with a Zeiss Axiovert 40C (Carl Zeiss Inc., Oberkochen, Germany)
inverted research-grade microscope equipped with a Canon EOS 1000D digital camera (magnification
20×).
4.7. Intraperitoneal Injection
After acclimation, juvenile fish were anesthetized (0.1 g/l MS-222) and received intraperitoneal
injections at 4.64 µL volume per g body mass. Treatments were as follows: CT (DMSO diluted 1:3
in sesame oil (S3547, Sigma-Aldrich, Tres-Cantos, Spain) as this was the vehicle for the estrogenic
compounds injections), GE at two doses, 5 and 50 µg/g body weight, and E2 at 5 µg/g (n = 6–9 fish).
Doses were selected according to previous studies in rainbow trout, with the low one being similar to
what is consumed on average by a fish fed with a soy-based diet, but not taking into account intestinal
absorption/metabolism events [23,25]. After 24 h, animals were anesthetized (0.1 g/l MS-222) and
blood samples were taken from the caudal vessels. After sacrifice by cranial concussion, samples of
visceral adipose tissue, liver, and white muscle were collected, immediately frozen in liquid nitrogen,
and stored at −80 ◦C until further analyses.
4.8. Biochemical Analysis of Culture Media and Plasma Metabolites
Glycerol and NEFA released into the cell culture media were measured for each experimental
condition and culture (n = 6 independent cultures). Moreover, plasma glucose, NEFA, and TAG were
analyzed in all sampled fish after the in vivo treatments (n = 6–9). All the procedures were done using
commercial enzymatic kits (Wako Chemicals GmbH, Neuss, Germany; Spinreact, Sant Esteve d’en Bas,
Spain and Monlab, Barcelona, Spain) following the manufacturers’ recommendations.
4.9. Gene Expression Analyses
4.9.1. RNA Extraction and cDNA Synthesis
Total RNA was extracted from adipose tissue (~100 mg), liver (~50 mg), and white muscle
(~100 mg), or from cell samples of two duplicate wells of the 6-well plates using 1 mL of TRI Reagent
(Applied Biosystems, Alcobendas, Spain), following the manufacturers’ recommendations. The quantity
of isolated RNA was determined using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific,
Alcobendas, Spain), and integrity of the samples was confirmed in a 1% agarose gel (w/v) stained
with SYBR-Safe DNA Gel Stain (Life Technologies, Alcobendas, Spain). In the case of the in vitro
samples, enough RNA from the GE 100 µM condition could not possibly be obtained, because of the
decrease caused in cell viability by this treatment, as explained in Section 2.1.1. Afterward, 1000 ng
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of total RNA was treated with DNase I (Invitrogen, Alcobendas, Spain) to remove all genomic DNA,
and reverse-transcribed with the Transcriptor First Strand cDNA Synthesis Kit (Roche, Sant Cugat del
Vallès, Spain).
4.9.2. Real-Time Quantitative PCR (qPCR)
The mRNA transcript levels of the target genes plus three reference genes were examined in a
CFX384™ real-time system (Bio-Rad, El Prat de Llobregat, Spain). Prior to the analyses, a dilution curve
with a pool of samples was run to validate primer efficiency, specificity of the reaction, and absence of
primer-dimers, as well as to determine the most appropriate cDNA working dilution required for each
gene. Reactions were performed in triplicate (methodological replicates) using 384-well plates with
2.5 µL of iTaq Universal SYBR Green Supermix (Bio-Rad, El Prat de Llobregat, Spain), 250 nM of final
concentration of forward and reverse primers (Table 3), and 1 µL of diluted cDNA for each sample,
in a final volume of 5 µL. As described before [64], the protocol started with an initial activation step of
3 min at 95 ◦C, 40 cycles of 10 s at 95 ◦C, and 30 s at 54–62 ◦C (primer-dependent, see Table 3) followed
by an amplicon dissociation analysis from 55 to 95 ◦C with a 0.5 ◦C increase each 30 s. The expression
level of each gene evaluated was calculated with the Pfaffl method [91], relative to the mean of the two
most stable reference genes, determined for each tissue by the geNorm algorithm implemented in the
Bio-Rad CFX manager v. 3.1 software.
Table 3. Primers used in the real-time quantitative PCR analyses.
Gene Primer Sequences (5′–3′) Tm, ◦C Accession Number
ubq F: ACAACATCCAGAAAGAGTCCAR: AGGCGAGCGTAGCACTTG 58 NM_001124194.1
ef1α F: TCCTCTTGGTCGTTTCGCTGR: ACCCGAGGGACATCCTGTG 58 NM_001124339.1
β-actin F: ATCCTGACGGAGCGCGGTTACAGCR: TGCCCATCTCCTGCTCAAAGTCCA 61 AJ438158
vtg F: GAGCTAAGGTCCGCACAATTGR: GGGAAACAGGGAAAGCTTCAA 58 X92804
fas F: GAGACCTAGTGGAGGCTGTCR: TCTTGTTGATGGTGAGCTGT 54 tcaa0001c.m.06_5.1.om.4
lpl F: TAATTGGCTGCAGAAAACACR: CGTCAGCAAACTCAAAGGT 59 AJ224693
hsl F: AGGGTCATGGTCATCGTCTCR: CTTGACGGAGGGACAGCTAC 58 TC172767
pparα F: CTGGAGCTGGATGACAGTGAR: GGCAAGTTTTTGCAGCAGAT 54 NM_001197211.1
pparβ F: CTGGAGCTGGATGACAGTAR: GTCAGCCATCTTGTTGAGCA 60 AY356399.1
gapdh F: TCTGGAAAGCTGTGGAGGGATGGAR: AACCTTCTTGATGGCATCATAGC 61 NM_001123561
lxr F: TGCAGCAGCCGTATGTGGAR: GCGGCGGGAGCTTCTTGTC 62 NM_001159338
casp3 F: TTTGGGAGTAGATTGCAGGGR: TGCACATCCACGATTTGATT 57 TC139042
casp8 F: CAGCATAGAGAAGCAAGGGGR: TGACTGAGGGGAGCTGAGTT 56 TC172513
p53 F: GTGGAATTTGATCCGAGTCTGTR: AGTGTCCAGGGTAGAATGGAG 56 -
lc3b F: GAACAGTTTGACCTGCGTGAAR: TCTCTCAATGATGACCGGAATCT 57 CA350545
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Table 3. Cont.
Gene Primer Sequences (5′–3′) Tm, ◦C Accession Number
atg4b F: TATGCGCTTCCGAAAGTTGTCR: CAGGATCGTTGGGTTTCTGC 58 CA345181.s.om.10
atg12l F: GATGGAGGCCAATGAACAGCR: GCGTTTGAACTGAAAAGGGCTAA 60 CB490089.s.om.10
ctsd F: GCCTGTCATCACATTCAACTR: CCACTCAGGCAGATGGTCTTA 55 NM_001124711
ctsl F: TGAAGGAGAAGATGTGGATGGR: TTCCTGTCTTTGGCCATGTAG 56 NM_001124305
F: Forward; R: Reverse; Tm: Melting temperature; ubq: Ubiquitin; ef1α: Elongation factor 1 alpha; β-actin:
Beta-actin; vtg: Vitellogenin; fas: Fatty acid synthase; lpl: Lipoprotein lipase; hsl: Hormone sensitive lipase; pparα:
Peroxisome proliferator-activated receptor alfa; pparβ: Peroxisome proliferator-activated receptor beta; gapdh:
Glyceraldehyde-3-phosphate dehydrogenase lxr: Liver x receptor; casp3: Caspase 3; casp8: Caspase 8; p53: Tumor
protein p53; lc3b: Microtubule-associated protein-1 light chain 3b; atg4b: Autophagy-related 4b cysteine peptidase;
atg12: Autophagy-related gene 12-like; ctsd: Cathepsin d; ctsl: Cathepsin l.
4.10. Statistical Analysis
Data were analyzed using IBM SPSS Statistics v. 22 (IBM, Armonk, NY, USA) and plotted as
mean + SEM with GraphPad Prism v. 7 (GraphPad Software, La Jolla, CA, USA, www.graphpad.com).
Data normality and homoscedasticity were tested using Shapiro–Wilk and Levene’s tests, respectively.
Statistical significance among groups was assessed by one-way analysis of variance (one-way ANOVA)
followed by Tukey’s post-hoc test. When homoscedasticity was not observed, Dunnett’s T3 test was
applied. Statistical differences were considered significant when the p-value was <0.05.
5. Conclusions
In summary, the present work reports that GE at a high dose reduces cell viability and shows a
tendency toward initiation of cell death in rainbow trout primary cultured preadipocytes, apparently
mainly involving an enhanced stimulation of autophagy but not an apoptotic process, consistent with
the gene expression changes observed both in vitro and in vivo. Nevertheless, caution is needed when
the assumption is made that changes in transcript abundance are reflected in protein levels and/or
enzyme activities, as numerous post-translational modifications and signaling pathways regulate these
two processes. In addition, GE, in contrast to findings in mammals, induces adipogenic effects in
the adipose tissue of this fish species, demonstrated through both in vitro and in vivo approaches.
The positive correlation between GE and VTG, together with the similar responses between GE
and E2 in lipid metabolism-related genes expression in adipose tissue and liver, suggest that this
phytocompound can produce an estrogenic effect and act as an E2-agonist in some target tissues. On the
whole, this study contributes to improving the knowledge on the impact of the dietary content of GE
that can be found in some VO used for FO replacement in aquafeeds, and confirms the importance of
testing and fine-tuning its amount on diets, as its effects are mainly dose-dependent. Consequently,
an elevated dietary GE content (e.g., soy ingredients) would lead to adipose tissue growth and lipid
metabolism impairment, mostly causing an excess in fat deposition in hypertrophic adipocytes, as a
result of decreased cell viability, that could affect the quality of the aquaculture product.
Author Contributions: Conceptualization, E.L., E.C. and I.N.; methodology, S.B.-P., E.L., N.R.-H., E.G.-N. and
E.J.V.; software, S.B.-P. and E.L.; validation, J.G., E.C. and I.N.; formal analysis, S.B.-P., E.L., E.C. and I.N.;
investigation, S.B.-P., E.L., N.R.-H., E.G.-N., E.J.V., J.G., E.C. and I.N.; resources, J.G., E.C. and I.N.; data curation,
S.B.-P., E.L., N.R.-H., E.G.-N., E.J.V., J.G., E.C. and I.N.; writing—original draft preparation, S.B.-P., E.L., E.C.
and I.N.; writing—review and editing, S.B.-P., E.L., N.R.-H., E.G.-N., E.J.V., J.G., E.C. and I.N.; visualization,
S.B.-P., E.L., N.R.-H., E.G.-N., E.J.V., J.G., E.C. and I.N.; supervision, E.C. and I.N.; project administration, J.G., E.C.
and I.N.; funding acquisition, J.G., E.C. and I.N. All authors have read and agreed to the published version of
the manuscript.
Int. J. Mol. Sci. 2020, 21, 5884 19 of 24
Funding: This research was funded from the Spanish “Ministerio de Ciencia, Innovación y Universidades”
(MICIUN) through the projects AGL2014-57974-R and AGL2017-89436-R to EC and IN, and the “Generalitat de
Catalunya” (2017SGR-1574). E.L., S.B.-P., N.R.-H. and E.J.V. were supported by predoctoral fellowships from the
MICIUN (BES-2012-061867, PRE-2018-085580, BES-2015-074654 and BES-2013-062949, respectively).
Acknowledgments: The authors would like to thank the personnel from the animal facilities of the Faculty of
Biology for the maintenance of the fish.








ef1α Elongation factor 1 alpha
E2 17β-Estradiol





LC3b Microtubule-associated protein-1 light chain 3b
lpl Lipoprotein lipase
lxr Liver x receptor
MTT Methylthiazolyldiphenyl-tetrazolium bromide
NAF Nuclear area factor
NEFA Non-esterified fatty acids
ORO Oil Red O staining
ppar Peroxisome proliferator-activated receptor






1. Food and Agriculture Organization of the United Nations. The State of World Fisheries and Aquaculture;
General Fisheries Commission for the Mediterranean: Rome, Italy, 2020.
2. Turchini, G.M.; Torstensen, B.E.; Ng, W.-K. Fish oil replacement in finfish nutrition. Rev. Aquac. 2009, 1,
10–57. [CrossRef]
3. Betancor, M.B.; Sprague, M.; Montero, D.; Usher, S.; Sayanova, O.; Campbell, P.J.; Napier, J.A.; Caballero, M.J.;
Izquierdo, M.; Tocher, D.R. Replacement of marine fish oil with de novo omega-3 oils from transgenic
camelina sativa in feeds for gilthead sea bream (Sparus aurata L.). Lipids 2016, 51, 1171–1191. [CrossRef]
[PubMed]
4. Calduch-Giner, J.A.; Sitjà-Bobadilla, A.; Davey, G.C.; Cairns, M.T.; Kaushik, S.; Pérez-Sánchez, J. Dietary
vegetable oils do not alter the intestine transcriptome of gilthead sea bream (Sparus aurata), but modulate
the transcriptomic response to infection with Enteromyxum leei. BMC Genom. 2012, 13, 1–13. [CrossRef]
[PubMed]
5. Pérez, J.A.; Rodríguez, C.; Bolaños, A.; Cejas, J.R.; Lorenzo, A. Beef tallow as an alternative to fish oil in diets
for gilthead sea bream (Sparus aurata) juveniles: Effects on fish performance, tissue fatty acid composition,
health and flesh nutritional value. Eur. J. Lipid Sci. Technol. 2014, 116, 571–583. [CrossRef]
Int. J. Mol. Sci. 2020, 21, 5884 20 of 24
6. Sánchez-Moya, A.; García-Meilán, I.; Riera-Heredia, N.; Vélez, E.J.; Lutfi, E.; Fontanillas, R.; Gutiérrez, J.;
Capilla, E.; Navarro, I. Effects of different dietary vegetable oils on growth and intestinal performance, lipid
metabolism and flesh quality in gilthead sea bream. Aquaculture 2020, 519. [CrossRef]
7. Godoy, A.C.; Santos, O.O.; Oxford, J.H.; de Amorim Melo, I.W.; Rodrigues, R.B.; Neu, D.; Vianna Nunes, R.;
Boscolo, W.R. Soybean oil for Nile tilapia (Oreochromis niloticus) in finishing diets: Economic, zootechnical
and nutritional meat improvements. Aquaculture 2019, 512, 734324. [CrossRef]
8. Lazzari, R.; Emanuelli, T.; Maschio, D.; Ferreira, C.C.; Battisti, E.K.; Radünz-Neto, J. The inclusion of soybean
oil in the diets of silver catfish (Rhamdia quelen) in relation to growth quality and fillet acceptability. Lat. Am.
J. Aquat. Res. 2016, 44, 39–45. [CrossRef]
9. Squadrito, F.; Marini, H.; Bitto, A.; Altavilla, D.; Polito, F.; Adamo, E.B.; D’Anna, R.; Arcoraci, V.; Burnett, B.P.;
Minutoli, L.; et al. Genistein in the metabolic syndrome: Results of a randomized clinical trial. J. Clin.
Endocrinol. Metab. 2013, 98, 3366–3374. [CrossRef]
10. Ferretti, G.; Bacchetti, T.; Menanno, F.; Curatola, G. Effect of genistein against copper-induced lipid
peroxidation of human high density lipoproteins (HDL). Atherosclerosis 2004, 172, 55–61. [CrossRef]
11. Foti, P.; Erba, D.; Riso, P.; Spadafranca, A.; Criscuoli, F.; Testolin, G. Comparison between daidzein and
genistein antioxidant activity in primary and cancer lymphocytes. Arch. Biochem. Biophys. 2005, 433, 421–427.
[CrossRef]
12. Banerjee, S.; Li, Y.; Wang, Z.; Sarkar, F.H. Multi-targeted therapy of cancer by genistein. Cancer Lett. 2008,
269, 226–242. [CrossRef] [PubMed]
13. Pavese, J.M.; Farmer, R.L.; Bergan, R.C. Inhibition of cancer cell invasion and metastasis by genistein.
Cancer Metastasis Rev. 2010, 29, 465–482. [CrossRef] [PubMed]
14. Behloul, N.; Wu, G. Genistein: A promising therapeutic agent for obesity and diabetes treatment. Eur. J.
Pharmacol. 2013, 698, 31–38. [CrossRef] [PubMed]
15. Cederroth, C.R.; Nef, S. Soy, phytoestrogens and metabolism: A review. Mol. Cell. Endocrinol. 2009, 304,
30–42. [CrossRef] [PubMed]
16. Szkudelska, K.; Nogowski, L. Genistein-A dietary compound inducing hormonal and metabolic changes.
J. Steroid Biochem. Mol. Biol. 2007, 105, 37–45. [CrossRef]
17. Hwang, J.T.; Park, I.J.; Shin, J.I.; Lee, Y.K.; Lee, S.K.; Baik, H.W.; Ha, J.; Park, O.J. Genistein, EGCG, and capsaicin
inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem. Biophys. Res.
Commun. 2005, 338, 694–699. [CrossRef]
18. Park, H.J.; Della-Fera, M.A.; Hausman, D.B.; Rayalam, S.; Ambati, S.; Baile, C.A. Genistein inhibits
differentiation of primary human adipocytes. J. Nutr. Biochem. 2009, 20, 140–148. [CrossRef]
19. Weng, L.; Zhang, F.; Wang, R.; Ma, W.; Song, Y. A review on protective role of genistein against oxidative
stress in diabetes and related complications. Chem. Biol. Interact. 2019, 310, 108665. [CrossRef]
20. Grossini, E.; Farruggio, S.; Raina, G.; Mary, D.; Deiro, G.; Gentilli, S. Effects of genistein on differentiation and
viability of human visceral adipocytes. Nutrients 2018, 10, 978. [CrossRef]
21. Lee, Y.M.; Choi, J.S.; Kim, M.H.; Jung, M.H.; Lee, Y.S.; Song, J. Effects of dietary genistein on hepatic lipid
metabolism and mitochondrial function in mice fed high-fat diets. Nutrition 2006, 22, 956–964. [CrossRef]
22. Mizushima, N.; Levine, B. Autophagy in development and differentiation. Adv. Exp. Med. Biol. 2010, 12,
823–830. [CrossRef]
23. Cleveland, B.M. In vitro and in vivo effects of phytoestrogens on protein turnover in rainbow trout
(Oncorhynchus mykiss) white muscle. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 2014, 165,
9–16. [CrossRef] [PubMed]
24. Olsvik, P.A.; Skjærven, K.H.; Søfteland, L. Metabolic signatures of bisphenol A and genistein in Atlantic
salmon liver cells. Chemosphere 2017, 189, 730–743. [CrossRef] [PubMed]
25. Cleveland, B.M.; Manor, M.L. Effects of phytoestrogens on growth-related and lipogenic genes in rainbow
trout (Oncorhynchus mykiss). Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 2015, 170, 28–37. [CrossRef]
26. Pinto, P.I.S.; Estêvão, M.D.; Andrade, A.; Santos, S.; Power, D.M. Tissue responsiveness to estradiol and
genistein in the sea bass liver and scale. J. Steroid Biochem. Mol. Biol. 2016, 158, 127–137. [CrossRef]
27. Sarasquete, C.; Úbeda-Manzanaro, M.; Ortiz-Delgado, J.B. Effects of the isoflavone genistein in early life
stages of the Senegalese sole, Solea senegalensis: Role of the Survivin and proliferation versus apoptosis
pathways. BMC Vet. Res. 2018, 14, 1–14. [CrossRef]
Int. J. Mol. Sci. 2020, 21, 5884 21 of 24
28. Lutfi, E.; Riera-Heredia, N.; Córdoba, M.; Porte, C.; Gutiérrez, J.; Capilla, E.; Navarro, I. Tributyltin and
triphenyltin exposure promotes in vitro adipogenic differentiation but alters the adipocyte phenotype in
rainbow trout. Aquat. Toxicol. 2017, 188, 148–158. [CrossRef]
29. Figueiredo-Silva, A.; Rocha, E.; Dias, J.; Silva, P.; Rema, P.; Gomes, E.; Valente, L.M.P. Partial replacement of
fish oil by soybean oil on lipid distribution and liver histology in European sea bass (Dicentrarchus labrax)
and rainbow trout (Oncorhynchus mykiss) juveniles. Aquac. Nutr. 2005, 11, 147–155. [CrossRef]
30. Mørkøre, T.; Netteberg, C.; Johnsson, L.; Pickova, J. Impact of dietary oil source on product quality of farmed
Atlantic cod, Gadus morhua. Aquaculture 2007, 267, 236–247. [CrossRef]
31. Peng, S.; Chen, L.; Qin, J.G.; Hou, J.; Yu, N.; Long, Z.; Ye, J.; Sun, X. Effects of replacement of dietary fish
oil by soybean oil on growth performance and liver biochemical composition in juvenile black seabream,
Acanthopagrus schlegeli. Aquaculture 2008, 276, 154–161. [CrossRef]
32. Rosenlund, G.; Oach, A.; Sandberg, M.G.; Standal, H.; Tveit, K. Effect of alternative lipid sources on long-term
growth performance and quality of Atlantic salmon (Salmo salar L.). Aquac. Res. 2001, 32, 323–328. [CrossRef]
33. Ruyter, B.; Moya-Falcón, C.; Rosenlund, G.; Vegusdal, A. Fat content and morphology of liver and intestine of
Atlantic salmon (Salmo salar): Effects of temperature and dietary soybean oil. Aquaculture 2006, 252, 441–452.
[CrossRef]
34. Levine, B.; Kroemer, G. Autophagy in the pathogenesis of disease. Cell 2008, 132, 27–42. [CrossRef] [PubMed]
35. Kroemer, G.; Levine, B. Autophagic cell death: The story of a misnomer. Nat. Rev. Mol. Cell. Biol. 2008, 9,
1004–1010. [CrossRef] [PubMed]
36. Daniel, B.; DeCoster, M.A. Quantification of sPLA2-induced early and late apoptosis changes in neuronal
cell cultures using combined TUNEL and DAPI staining. Brain Res. Protoc. 2004, 13, 144–150. [CrossRef]
37. Mizushima, N. Methods for monitoring autophagy. Int. J. Biochem. Cell Biol. 2004, 36, 2491–2502. [CrossRef]
38. Zhang, Y.; Zeng, X.; Jin, S. Autophagy in adipose tissue biology. Pharmacol. Res. 2012, 66, 505–512. [CrossRef]
39. Klionsky, D.J.; Abdelmohsen, K.; Abe, A.; Abedin, M.J.; Abeliovich, H.; Arozena, A.A.; Adachi, H.;
Adams, C.M.; Adams, P.D.; Adeli, K.; et al. Guidelines for the use and interpretation of assays for monitoring
autophagy. Autophagy 2016, 12, 1–222. [CrossRef]
40. Gossner, G.; Choi, M.; Tan, L.; Fogoros, S.; Griffith, K.A.; Kuenker, M.; Liu, J.R. Genistein-induced apoptosis
and autophagocytosis in ovarian cancer cells. Gynecol. Oncol. 2007, 105, 23–30. [CrossRef]
41. Prietsch, R.F.; Monte, L.G.; Da Silva, F.A.; Beira, F.T.; Del Pino, F.A.B.; Campos, V.F.; Collares, T.; Pinto, L.S.;
Spanevello, R.M.; Gamaro, G.D.; et al. Genistein induces apoptosis and autophagy in human breast MCF-7
cells by modulating the expression of proapoptotic factors and oxidative stress enzymes. Mol. Cell. Biochem.
2014, 390, 235–242. [CrossRef]
42. Kim, D.J.; Seok, S.H.; Baek, M.W.; Lee, H.Y.; Na, Y.R.; Park, S.H.; Lee, H.K.; Dutta, N.K.; Kawakami, K.;
Park, J.H. Developmental toxicity and brain aromatase induction by high genistein concentrations in zebrafish
embryos. Toxicol. Mech. Methods 2009, 19, 251–256. [CrossRef] [PubMed]
43. Sarasquete, C.; Úbeda-Manzanaro, M.; Ortiz-Delgado, J.B. Toxicity and non-harmful effects of the soya
isoflavones, genistein and daidzein, in embryos of the zebrafish, Danio rerio. Comp. Biochem. Physiol. Part C
Toxicol. Pharmacol. 2018, 211, 57–67. [CrossRef] [PubMed]
44. Sassi-Messai, S.; Gibert, Y.; Bernard, L.; Nishio, S.I.; Ferri Lagneau, K.F.; Molina, J.; Andersson-Lendahl, M.;
Benoit, G.; Balaguer, P.; Laudet, V. The phytoestrogen genistein affects zebrafish development through two
different pathways. PLoS ONE 2009, 4. [CrossRef] [PubMed]
45. Stienstra, R.; Haim, Y.; Riahi, Y.; Netea, M.; Rudich, A.; Leibowitz, G. Autophagy in adipose tissue and the
beta cell: Implications for obesity and diabetes. Diabetologia 2014, 57, 1505–1516. [CrossRef] [PubMed]
46. Salmerón, C. Adipogenesis in fish. J. Exp. Biol. 2018, 121, 1–11. [CrossRef]
47. Lowe, C.E.; O’Rahilly, S.; Rochford, J.J. Adipogenesis at a glance. J. Cell Sci. 2011, 124, 2681–2686. [CrossRef]
48. Zhang, C.; He, Y.; Okutsu, M.; Ong, L.C.; Jin, Y.; Zheng, L.; Chow, P.; Yu, S.; Zhang, M.; Yan, Z. Autophagy is
involved in adipogenic differentiation by repressesing proteasome-dependent PPARγ2 degradation. Am. J.
Physiol. Endocrinol. Metab. 2013, 305, 530–539. [CrossRef]
49. Bou, M.; Montfort, J.; Le Cam, A.; Rallière, C.; Lebret, V.; Gabillard, J.C.; Weil, C.; Gutiérrez, J.; Rescan, P.Y.;
Capilla, E.; et al. Gene expression profile during proliferation and differentiation of rainbow trout adipocyte
precursor cells. BMC Genom. 2017, 18, 1–20. [CrossRef]
Int. J. Mol. Sci. 2020, 21, 5884 22 of 24
50. Rayalam, S.; Della-Fera, M.A.; Yang, J.-Y.; Park, H.J.; Ambati, S.; Baile, C.A. Resveratrol potentiates genistein’s
antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes. J. Nutr. 2007, 137, 2668–2673. [CrossRef]
51. Harmon, A.W.; Harp, J.B. Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. Am. J.
Physiol. Cell Physiol. 2001, 280, 807–813. [CrossRef]
52. Dang, Z.C. Dose-dependent effects of soy phyto-oestrogen genistein on adipocytes: Mechanisms of action.
Obes. Rev. 2009, 10, 342–349. [CrossRef] [PubMed]
53. Zhang, L.Y.; Xue, H.G.; Chen, J.Y.; Chai, W.; Ni, M. Genistein induces adipogenic differentiation in human
bone marrow mesenchymal stem cells and suppresses their osteogenic potential by upregulating PPARγ.
Exp. Ther. Med. 2016, 11, 1853–1858. [CrossRef] [PubMed]
54. Haux, C.; Norberg, B. The influence of estradiol-17β on the liver content of protein, lipids, glycogen and
nucleic acids in juvenile rainbow trout, Salmo gairdnerii. Comp. Biochem. Physiol. Part B Comp. Biochem. 1985,
81, 275–279. [CrossRef]
55. Shen, M.; Shi, H. Sex hormones and their receptors regulate liver energy homeostasis. Int. J. Endocrinol. 2015,
2015, 1–12. [CrossRef] [PubMed]
56. Turner, P.V.; Brabb, T.; Pekow, C.; Vasbinder, M.A. Administration of substances to laboratory animals:
Routes of administration and factors to consider. J. Am. Assoc. Lab. Anim. Sci. 2011, 50, 600–613. [PubMed]
57. He, A.Y.; Ning, L.J.; Chen, L.Q.; Chen, Y.L.; Xing, Q.; Li, J.M.; Qiao, F.; Li, D.L.; Zhang, M.L.; Du, Z.Y. Systemic
adaptation of lipid metabolism in response to low- and high-fat diet in Nile tilapia (Oreochromis niloticus).
Physiol. Rep. 2015, 3, 1–18. [CrossRef]
58. Davis, L.K.; Fox, B.K.; Lim, C.; Hiramatsu, N.; Sullivan, C.V.; Hirano, T.; Grau, E.G. Induction of vitellogenin
production in male tilapia (Oreochromis mossambicus) by commercial fish diets. Comp. Biochem. Physiol. Part
A Mol. Integr. Physiol. 2009, 154, 249–254. [CrossRef]
59. Andreassen, T.K.; Skjoedt, K.; Korsgaard, B. Upregulation of estrogen receptor α and vitellogenin in eelpout
(Zoarces viviparus) by waterborne exposure to 4-tert-octylphenol and 17β-estradiol. Comp. Biochem. Physiol.
Part C Toxicol. Pharmacol. 2005, 140, 340–346. [CrossRef]
60. Bowman, C.J.; Kroll, K.J.; Gross, T.G.; Denslow, N.D. Estradiol-induced gene expression in largemouth bass
(Micropterus salmoides). Mol. Cell. Endocrinol. 2002, 196, 67–77. [CrossRef]
61. Leaños-Castañeda, O.; Van Der Kraak, G. Functional characterization of estrogen receptor subtypes, ERα
and ERβ, mediating vitellogenin production in the liver of rainbow trout. Toxicol. Appl. Pharmacol. 2007, 224,
116–125. [CrossRef]
62. Ishibashi, H.; Tachibana, K.; Tsuchimoto, M.; Soyano, K.; Tatarazako, N.; Matsumura, N.; Tomiyasu, Y.;
Tominaga, N.; Arizono, K. Effects of nonylphenol and phytoestrogen-enriched diet on plasma vitellogenin,
steroid hormone, hepatic cytochrome P450 1A, and glutathione-S-transferase values in Goldfish
(Carassius auratus). Comp. Med. 2004, 54, 54–62. [PubMed]
63. Cruz-Garcia, L.; Sánchez-Gurmaches, J.; Gutiérrez, J.; Navarro, I. Role of LXR in trout adipocytes: Target
genes, hormonal regulation, adipocyte differentiation and relation to lipolysis. Comp. Biochem. Physiol. Part
A Mol. Integr. Physiol. 2012, 163, 120–126. [CrossRef] [PubMed]
64. Salmerón, C.; Riera-Heredia, N.; Gutiérrez, J.; Navarro, I.; Capilla, E. Adipogenic gene expression in gilthead
sea bream mesenchymal stem cells from different origin. Front. Endocrinol. 2016, 7, 1–13. [CrossRef]
[PubMed]
65. Naaz, A.; Yellayi, S.; Zakroczymski, M.A.; Bunick, D.; Doerge, D.R.; Lubahn, D.B.; Helferich, W.G.; Cooke, P.S.
The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology 2003, 144, 3315–3320.
[CrossRef] [PubMed]
66. Xin, X.; Chen, C.; Hu, Y.Y.; Feng, Q. Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD).
Biomed. Pharmacother. 2019, 117, 109047. [CrossRef] [PubMed]
67. Li, Y.; Upadhyay, S.; Bhuiyan, M.; Sarkar, F.H. Induction of apoptosis in breast cancer cells MDA-MB-231 by
genistein. Oncogene 1999, 18, 3166–3172. [CrossRef] [PubMed]
68. Yu, Z.; Li, W.; Liu, F. Inhibition of proliferation and induction of apoptosis by genistein in colon cancer HT-29
cells. Cancer Lett. 2004, 215, 159–166. [CrossRef]
69. Choi, E.J.; Lee, B.H. Evidence for genistein mediated cytotoxicity and apoptosis in rat brain. Life Sci. 2004, 75,
499–509. [CrossRef]
Int. J. Mol. Sci. 2020, 21, 5884 23 of 24
70. Kim, H.-K.; Nelson-Dooley, C.; Della-Fera, M.A.; Yang, J.-Y.; Zhang, W.; Duan, J.; Hartzell, D.L.; Hamrick, M.W.;
Baile, C.A. Genistein decreases food intake, body weight, and fat pad weight and causes adipose tissue
apoptosis in ovariectomized female mice. J. Nutr. 2006, 136, 409–414. [CrossRef]
71. Della-Fera, M.A.; Qian, H.; Baile, C.A. Adipocyte apoptosis in the regulation of body fat mass by leptin.
Diabetes, Obes. Metab. 2001, 3, 299–310. [CrossRef]
72. Gullicksen, P.S.; Hausman, D.B.; Dean, R.G.; Hartzell, D.L.; Baile, C.A. Adipose tissue cellularity and
apoptosis after intracerebroventricular injections of leptin and 21 days of recovery in rats. Int. J. Obes. 2003,
27, 302–312. [CrossRef] [PubMed]
73. Jung, J.Y.; Roh, K.H.; Jeong, Y.J.; Kim, S.H.; Lee, E.J.; Kim, M.S.; Oh, W.M.; Oh, H.K.; Kim, W.J. Estradiol
protects PC12 cells against CoCl2-induced apoptosis. Brain Res. Bull. 2008, 76, 579–585. [CrossRef] [PubMed]
74. Patten, R.D.; Pourati, I.; Aronovitz, M.J.; Baur, J.; Celestin, F.; Chen, X.; Michael, A.; Haq, S.; Nuedling, S.;
Grohe, C.; et al. 17β-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of
Phospho-inositide-3 kinase/Akt signaling. Circ. Res. 2004, 95, 692–699. [CrossRef] [PubMed]
75. Suzuki, R.; Kang, Y.; Li, X.; Roife, D.; Zhang, R.; Fleming, J.B. Genistein potentiates the antitumor effect of
5-fluorouracil by inducing apoptosis and autophagy in human pancreatic cancer cells. Anticancer Res. 2014,
34, 4685–4692.
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